BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21348818)

  • 1. HLA-G expression in cancers: potential role in diagnosis, prognosis and therapy.
    Yan WH
    Endocr Metab Immune Disord Drug Targets; 2011 Mar; 11(1):76-89. PubMed ID: 21348818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-G expression in hematologic malignancies.
    Yan WH
    Expert Rev Hematol; 2010 Feb; 3(1):67-80. PubMed ID: 21082935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-G: on the track of immunological functions.
    Le Bouteiller P
    Eur J Immunogenet; 1997 Oct; 24(5):397-408. PubMed ID: 9442807
    [No Abstract]   [Full Text] [Related]  

  • 4. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond the increasing complexity of the immunomodulatory HLA-G molecule.
    Carosella ED; Favier B; Rouas-Freiss N; Moreau P; Lemaoult J
    Blood; 2008 May; 111(10):4862-70. PubMed ID: 18334671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of HLA-G in immunity and hematopoiesis.
    Carosella ED; Gregori S; Rouas-Freiss N; LeMaoult J; Menier C; Favier B
    Cell Mol Life Sci; 2011 Feb; 68(3):353-68. PubMed ID: 21116680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-G and MIC expression in tumors and their role in anti-tumor immunity.
    Seliger B; Abken H; Ferrone S
    Trends Immunol; 2003 Feb; 24(2):82-7. PubMed ID: 12547505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capacity of myeloid and plasmacytoid dendritic cells especially at mature stage to express and secrete HLA-G molecules.
    Le Friec G; Gros F; Sebti Y; Guilloux V; Pangault C; Fauchet R; Amiot L
    J Leukoc Biol; 2004 Dec; 76(6):1125-33. PubMed ID: 15331623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrameric complexes of HLA-E, HLA-F, and HLA-G.
    Allan DS; Lepin EJ; Braud VM; O'Callaghan CA; McMichael AJ
    J Immunol Methods; 2002 Oct; 268(1):43-50. PubMed ID: 12213342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?
    Amiot L; Ferrone S; Grosse-Wilde H; Seliger B
    Cell Mol Life Sci; 2011 Feb; 68(3):417-31. PubMed ID: 21063893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leukocyte antigen-G (HLA-G) as a marker for diagnosis, prognosis and tumor immune escape in human malignancies.
    Yie SM; Hu Z
    Histol Histopathol; 2011 Mar; 26(3):409-20. PubMed ID: 21210353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance.
    Carosella ED; Moreau P; Le Maoult J; Le Discorde M; Dausset J; Rouas-Freiss N
    Adv Immunol; 2003; 81():199-252. PubMed ID: 14711057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17.
    Agaugué S; Carosella ED; Rouas-Freiss N
    Blood; 2011 Jun; 117(26):7021-31. PubMed ID: 21482709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.
    Shiroishi M; Tsumoto K; Amano K; Shirakihara Y; Colonna M; Braud VM; Allan DS; Makadzange A; Rowland-Jones S; Willcox B; Jones EY; van der Merwe PA; Kumagai I; Maenaka K
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8856-61. PubMed ID: 12853576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-G molecule.
    Kamishikiryo J; Maenaka K
    Curr Pharm Des; 2009; 15(28):3318-24. PubMed ID: 19860681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of human leukocyte antigen-G expression in the diagnosis of human cancer.
    Shih IeM
    Hum Immunol; 2007 Apr; 68(4):272-6. PubMed ID: 17400063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune-refractory cancers and their little helpers--an extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?
    Wischhusen J; Waschbisch A; Wiendl H
    Semin Cancer Biol; 2007 Dec; 17(6):459-68. PubMed ID: 17768067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association.
    Donadi EA; Castelli EC; Arnaiz-Villena A; Roger M; Rey D; Moreau P
    Cell Mol Life Sci; 2011 Feb; 68(3):369-95. PubMed ID: 21107637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells.
    Allan DS; Colonna M; Lanier LL; Churakova TD; Abrams JS; Ellis SA; McMichael AJ; Braud VM
    J Exp Med; 1999 Apr; 189(7):1149-56. PubMed ID: 10190906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do nonhuman primates comprise appropriate experimental models for studying the function of human leukocyte antigen-G?
    Langat DK; Hunt JS
    Biol Reprod; 2002 Nov; 67(5):1367-74. PubMed ID: 12390864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.